The next creation sequencing industry is quickly changing with a huge number of improvements going on to improve precision and rate, and website of sequencing. It is the fastest-growing and most profitable section in the genomics space with an approximated development of 16.3%. The international NGS industry was respected at $1.3 billion dollars this year and is positioned to achieve $2.7 billion dollars by 2017. By assisting genomics research, various regulators like NHGRI (National Human Genome Research Institution, U.S.) and Medical and Technological Sciences Research Authorities (BBSRC, U.K.) are improving the adopting of high-throughput sequencing systems.
The development of the overall NGS industry is motivated by ongoing enhancements and improvements in the marketplace targeted at higher throughput, improved precision, and cost-effective expenses. However, aspects such as great stability on allows and financing from the govt, and loss of investment expenses from educational organizations are effecting the development of the industry. Moreover, the presentation of big information produced by sequencers and the following storage space and control of the examined information is still a task. Due to the complexness of NGS technology and information, standardization of the overall NGS work-flow provides an unmet need. The possibilities for the development of this industry consist of improvements in the pre-sequencing, reasoning processing, and NGS bioinformatics alternatives.
The NGS systems industry was protected with Illumina this year, which included the biggest business of 56%. Other companies with professional systems consist of Life Technological innovation (U.S.), 454 Roche (U.S.), and Hawaiian Biosciences (U.S.). The lately presented Bench-top and NGS systems will generate the industry. Based on actions in the NGS work-flow, the overall NGS industry has three significant sections, namely, pre-sequencing, NGS systems and services, and NGS information research, storage space and control.
1 INTRODUCTION 24
1.1 KEY TAKE-AWAYS 24
1.2 REPORT DESCRIPTION 24
1.3 MARKETS COVERED 26
1.4 STAKEHOLDERS 28
1.5 RESEARCH METHODOLOGY 29
1.5.1 MARKET SIZE 29
1.5.2 MARKET SHARE 30
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES 30
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES 31
1.5.5 ASSUMPTIONS 32
2 EXECUTIVE SUMMARY 33
3 MARKET OVERVIEW 38
3.1 INTRODUCTION 39
3.2 EVOLUTION 40
3.3 MARKET SEGMENTATION 41
3.4 MARKET DYNAMICS 43
3.4.1 DRIVERS 44
3.4.1.1 Cost and Speed to Drive the Development of NGS Technological innovation 44
3.4.1.2 Replacement of Microarray Technological innovation by NGS to Increase Market Growth 44
3.4.1.3 Embracement of NGS Technological innovation by New Customers to Drive the Market 46
3.4.1.4 Surge in Exercise for New Technological Programs to Boost the Growth 46
3.4.1.5 Research Labs and Academicians Advertising the Use of NGS 46
3.4.2 RESTRAINTS 47
3.4.2.1 High Reliability on Grants to Limit Growth 47
3.4.2.2 Decrease in Capital Expenditure from Educational Institutions to Limit the Selling of Platforms 47
3.4.2.3 Accuracy & Standardization, a Issue in Analytic Examining 48
3.4.3 OPPORTUNITIES 49
3.4.3.1 Customized Medication & Biomarker Development Open Methods for Investment strategies in NGS Technological innovation 49
Related Review : http://www.aarkstore.com/market-sector-reports/Biotechnology-9.html
aarkresearchreport 